JGC
J. Goldman & Co Portfolio holdings
AUM
$3.18B
This Quarter Return
+5.74%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$595M
AUM Growth
+$595M
(-0.73%)
Cap. Flow
-$33.9M
Cap. Flow
% of AUM
-5.7%
Top 10 Holdings %
Top 10 Hldgs %
30.68%
Holding
332
New
92
Increased
28
Reduced
27
Closed
101
Top Buys
| 1 |
Apple
AAPL
|
$51.4M |
| 2 |
CAB
Cabela's Inc
CAB
|
$18.8M |
| 3 |
Norwegian Cruise Line
NCLH
|
$16.6M |
| 4 |
Brinker International
EAT
|
$16.1M |
| 5 |
XOOM
XOOM CORP COM
XOOM
|
$12M |
Top Sells
| 1 |
Mondelez International
MDLZ
|
$27.2M |
| 2 |
Estee Lauder
EL
|
$19.3M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$18.8M |
| 4 |
Ralph Lauren
RL
|
$16.6M |
| 5 |
Zoetis
ZTS
|
$14.8M |
Sector Composition
| 1 | Technology | 18.77% |
| 2 | Consumer Discretionary | 17.16% |
| 3 | Industrials | 10.73% |
| 4 | Healthcare | 7.69% |
| 5 | Energy | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vital Energy
VTLE
$682M
| $1.48M | 0.14% |
+50,000
| New | +$1.48M |
|
|
ENVI
102
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $1.28M | 0.12% |
407,301
-21,194
| -5% | -$66.6K |
|
103
Medifast
MED
$153M
| $1.21M | 0.11% |
+45,000
| New | +$1.21M |
|
|
CPN
104
DELISTED
Calpine Corporation
CPN
| $1.21M | 0.11% |
+62,288
| New | +$1.21M |
|
105
American Express
AXP
$225B
| $1.13M | 0.11% |
+15,000
| New | +$1.13M |
|
106
Groupon
GRPN
$990M
| $1.12M | 0.11% |
100,000
-1,130,000
| -92% | -$12.7M |
|
|
HNR
107
DELISTED
Harvest Natural Resources
HNR
| $1.11M | 0.1% |
207,491
-132,928
| -39% | -$711K |
|
108
Medtronic
MDT
$118B
| $1.07M | 0.1% |
+20,000
| New | +$1.07M |
|
109
Marvell Technology
MRVL
$53.7B
| $1.06M | 0.1% |
+92,500
| New | +$1.06M |
|
110
SIGA Technologies
SIGA
$617M
| $1.04M | 0.1% |
273,376
| – | – |
|
111
Salesforce
CRM
$245B
| $1.04M | 0.1% |
+20,000
| New | +$1.04M |
|
112
Boston Scientific
BSX
$159B
| $1.03M | 0.1% |
+88,000
| New | +$1.03M |
|
113
Stryker
SYK
$149B
| $1.01M | 0.1% |
+15,000
| New | +$1.01M |
|
114
Entergy
ETR
$38.9B
| $994K | 0.09% |
+15,723
| New | +$994K |
|
115
Zimmer Biomet
ZBH
$20.8B
| $986K | 0.09% |
+12,000
| New | +$986K |
|
116
TIM SA
TIMB
$10.1B
| $933K | 0.09% |
+39,578
| New | +$933K |
|
117
Gyre Therapeutics
GYRE
$734M
| $929K | 0.09% |
+175,000
| New | +$929K |
|
|
ANAC
118
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $929K | 0.09% |
+87,500
| New | +$929K |
|
119
Fidelity National Financial
FNF
$16.2B
| $908K | 0.09% |
+34,147
| New | +$908K |
|
120
Vanda Pharmaceuticals
VNDA
$279M
| $876K | 0.08% |
80,000
-87,000
| -52% | -$953K |
|
121
Louisiana-Pacific
LPX
$6.48B
| $862K | 0.08% |
49,000
+35,000
| +250% | +$616K |
|
122
DURECT Corp
DRRX
$60.2M
| $858K | 0.08% |
640,139
+377,639
| +144% | +$506K |
|
|
OPTR
123
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $819K | 0.08% |
+65,066
| New | +$819K |
|
124
Achieve Life Sciences
ACHV
$146M
| $811K | 0.08% |
87,500
-135,407
| -61% | -$1.24M |
|
125
OraSure Technologies
OSUR
$230M
| $811K | 0.08% |
+135,000
| New | +$811K |
|